Electric Literature of 1317-39-1, In heterogeneous catalysis, catalysts provide a surface to which reactants bind in a process of adsorption. Enzyme inhibitors cause a decrease in the reaction rate of an enzyme-catalyzed reaction.In an article, once mentioned the application of 1317-39-1, Name is Copper(I) oxide, is a conventional compound.
Compounds of formula (I) wherein R 1, R 2, R 3 and R 4 are each H or C 1-C 4 alkyl; R 5 is (CH 2) m NHSO. sub.2 R 6 or (CH) m NHCOR 6 ; R 6 is C 1-C 6 alkyl, C 3-C 6 cycloalkyl optionally substituted by aryl, aryl or heteroaryl; R 7 is H, C 1-C 4 alkyl, C 1-C 4 alkoxy, halo, CF. sub.3, OCF 3, CN, CONH 2, or S(O) n (C 1-C 4 alkyl); X is CH 2, CHCH 3, CH(OH), C(OH)CH 3, C= CH 2, CO or O; m is 0 or 1 and n is 0, 1 or 2, and their pharmaceutically acceptable salts and biolabile esters, are antagonists of thromboxane A 2 of utility, particulary in combination with a thromboxane synthetase inhibitor, in the treatment of atherosclerosis and unstable angina and for prevention of reocclusion after percutaneous transluminal angioplasty.
One of the oldest and most widely used commercial enzyme inhibitors is aspirin, Electric Literature of 1317-39-1, which selectively inhibits one of the enzymes involved in the synthesis of molecules that trigger inflammation. you can also check out more blogs about 1317-39-1
Reference：
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”